China Medical & HealthCare Group Limited
COLRF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,627,199 | $1,568,824 | $1,438,865 | $1,476,540 |
| % Growth | 3.7% | 9% | -2.6% | – |
| Cost of Goods Sold | $1,302,646 | $1,282,604 | $1,277,000 | $1,300,566 |
| Gross Profit | $324,553 | $286,220 | $161,865 | $175,974 |
| % Margin | 19.9% | 18.2% | 11.2% | 11.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $223,682 | $231,007 | $255,214 | $222,764 |
| SG&A Expenses | $230,553 | $236,758 | $259,250 | $225,431 |
| Sales & Mktg Exp. | $6,871 | $5,751 | $4,036 | $2,667 |
| Other Operating Expenses | -$1,667 | -$33,749 | -$201,124 | -$197,035 |
| Operating Expenses | $238,435 | $203,009 | $201,124 | $197,035 |
| Operating Income | $86,118 | $83,211 | -$39,259 | -$21,061 |
| % Margin | 5.3% | 5.3% | -2.7% | -1.4% |
| Other Income/Exp. Net | -$29,114 | -$47,807 | -$59,015 | -$58,248 |
| Pre-Tax Income | $57,004 | $35,404 | -$117,169 | -$110,468 |
| Tax Expense | $15,028 | $14,912 | $1,976 | $16,802 |
| Net Income | $28,773 | $11,295 | -$123,574 | -$137,296 |
| % Margin | 1.8% | 0.7% | -8.6% | -9.3% |
| EPS | 0.027 | 0.012 | -0.17 | -0.19 |
| % Growth | 117.2% | 107.2% | 10.5% | – |
| EPS Diluted | 0.027 | 0.012 | -0.17 | -0.19 |
| Weighted Avg Shares Out | 1,086,001 | 923,826 | 732,048 | 732,048 |
| Weighted Avg Shares Out Dil | 1,086,001 | 923,826 | 732,048 | 732,048 |
| Supplemental Information | – | – | – | – |
| Interest Income | $32,497 | $24,466 | $3,958 | $1,423 |
| Interest Expense | $29,114 | $47,807 | $59,015 | $58,248 |
| Depreciation & Amortization | $97,307 | $98,218 | $104,693 | $104,529 |
| EBITDA | $183,425 | $174,828 | $46,539 | $52,309 |
| % Margin | 11.3% | 11.1% | 3.2% | 3.5% |